CSI Market
Sign In | Register

Mirum Pharmaceuticals Inc (MIRM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MIRM Annual Cash Flow →
This cash flow overview for Mirum Pharmaceuticals Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-857.38
Depreciation & amortization13.81
Amortization of Other Assets14.61
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories1.53
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation154.82
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-1.99
Operating Lease Right Of Use Asset Amortization-
Amortization Of Premium On Investments-
Increase Decrease In Operating Lease Right Of Use Asset-
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities57.24
Non Cash Interest Expense On Revenue Interest Purchase Agreement-
Non Cash Lease Expense0.55
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements-
Change In Fair Value Of Contingent Liabilities Associated With Acquisition-
Inventory Reserves Under Operating Activity-
Inventory Reserves And Firm Purchase Commitment Losses Under Operating Activity-
Costs Recognized On Sale Of Acquired Inventory-
Tax Benefit Associated With An Acquisition-
Gain On Sale Of Priority Review Voucher Net-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable26.63
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets7.71
Other Working Capital10.63
Other Noncash Income (Expense)0.58
Other net0.00
Payments for (Proceeds from) Other Operating Activities356.04
Discontinued operations0.00
Net Cash flow from Operating Activities-273.02
Investing Activities
Capital Expenditures-35.69
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities59.74
Short-term Investments Acq.0.00
Payments for Tenant Improvements0.00
Proceeds From Paydowns Of Investments-
Proceeds From Sale Of Priority Review Voucher Net-
Additions To Intangible Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-195.61
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-1.68
Discontinued operations0.00
Net Cash Flow from Investing Activities-171.56
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-17.57
Long-term debt - borrowings672.44
Long-term debt - repayments-474.37
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock283.45
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net17.57
Payment Of Issuance Costs Related To The Revenue Interest Liability-
Proceeds Of Issuance Costs Related To The Revenue Interest Liability-
Proceeds From Revenue Interest Liability-
Repayment Of Revenue Interest-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations298.17
Operating Lease Payments0.81
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities481.52
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-308.70
Total Cash Flow34.30
4 historic quarters locked

Sign in to unlock the full Mirum Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Mirum Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001759425-26-000045

Figures are derived from filed reports and may be restated. Historical data is subject to revision.